SCHEMBL28360424

SCHEMBL28360424

CCN(CC)C(Cl)Cl.CN(N)Cc1ccccc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AOC3 Q16853 5/20 0.66
▸ ALDH1A1 P00352 3/20 0.44
▸ TSHR P16473 2/20 0.44
▸ NPC1 O15118 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ CARM1 Q86X55 1/20 0.41
▸ PRMT6 Q96LA8 1/20 0.41
▸ PRMT8 Q9NR22 1/20 0.41
▸ MGLL Q99685 2/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ ADRA2B P18089 1/20 0.40
▸ ADRA2C P18825 1/20 0.40
▸ SLC6A2 P23975 1/20 0.40
▸ HTR2A P28223 1/20 0.40
▸ SLC6A4 P31645 1/20 0.40
▸ ADRA1A P35348 1/20 0.40
▸ OPRK1 P41145 1/20 0.40
▸ SLC6A3 Q01959 1/20 0.40
▸ KCNH2 Q12809 1/20 0.40
▸ HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1164941 0.81 AOC3 (1.00) AOC3ALDH1A1TSHRNPC1RAB9A
SCHEMBL1793814 0.81 AOC3 (1.00) AOC3ALDH1A1TSHRNPC1RAB9A
Hydrazine SCHEMBL28353884 0.79 AOC3 (0.95) AOC3ALDH1A1TSHRNPC1RAB9A
Hydrochloric Acid SCHEMBL4696173 0.79 AOC3 (0.95) AOC3ALDH1A1TSHRNPC1RAB9A
Hydrochloric Acid SCHEMBL11186055 0.79 AOC3 (0.95) AOC3ALDH1A1TSHRNPC1RAB9A
Ammonia Solution, Strong SCHEMBL28459179 0.79 AOC3 (0.95) AOC3ALDH1A1TSHRNPC1RAB9A
Bromide SCHEMBL28239009 0.77 AOC3 (0.91) AOC3ALDH1A1TSHRNPC1RAB9A
SCHEMBL28765479 0.71 TSHR (0.47) AOC3ALDH1A1TSHRCARM1PRMT6
SCHEMBL11750385 0.70 AOC3 (0.75) AOC3ALDH1A1TSHRCARM1PRMT6
SCHEMBL12124877 0.70 TSHR (0.50) AOC3ALDH1A1TSHRNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117015396-A Compositions and methods for treating cancer with chimeric TIM receptors in combination with poly (ADP-ribose) polymerase inhibitors 森罗治疗公司 2023-11-07 — — CN disclosed
CN-116390936-A Chimeric TIM receptors and uses thereof 森罗治疗公司 2023-07-04 — — CN disclosed
CN-112867512-A Combination therapy 意大利国际先进加速器应用有限公司 2021-05-28 — — CN disclosed
CN-107667092-B Formylated N-heterocyclic derivatives as FGFR4 inhibitors 诺华股份有限公司 2021-05-28 — — CN disclosed
CN-112584901-A Methods and compositions for blocking interactions between non-glycosylated PD-1 polypeptides 真和制药有限公司 2021-03-30 — — CN disclosed
CN-112218886-A Expression vector of chimeric phagocytic receptor, genetically modified host cell and application thereof 森罗治疗公司 2021-01-12 — — CN disclosed
CN-112218887-A Cellular immunotherapy compositions and uses thereof 森罗治疗公司 2021-01-12 — — CN disclosed
CN-112218651-A Immunopotentiating RNA for combination with chimeric antigen receptor therapy 诺华公司 2021-01-12 — — CN disclosed
CN-111770759-A Targeting the CBM-signalosome complex to induce regulatory T cells to inflame the tumor microenvironment 通用医疗公司 2020-10-13 — — CN disclosed
CN-111386284-A Chimeric phagocytic receptor molecules and methods of use 森罗治疗公司 2020-07-07 — — CN disclosed
CN-110799640-A T cells expressing chimeric antigen receptors 综合医院公司 2020-02-14 — — CN disclosed
Send feedback